Cinacalcet treatment of primary hyperparathyroidism

International Journal of Endocrinology

Volumn 2011, Issue , 2011, Pages

  Rothe, H M ^a   Liangos, O ^a   Biggar, P ^a   Petermann, A ^a   Ketteler, M ^a  

^a KLINIKUM COBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMIMETIC AGENT; CALCIUM; CINACALCET; PARATHYROID HORMONE; PHOSPHORUS; PLACEBO;

ARTHRALGIA; BONE DENSITY; COGNITIVE DEFECT; DIARRHEA; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; GENETIC RISK; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATURIA; KIDNEY TRANSPLANTATION; MYALGIA; NAUSEA; NEPHROLITHIASIS; OSTEITIS FIBROSA; PARATHYROIDECTOMY; PHOSPHATURIA; PRIMARY BILIARY CIRRHOSIS; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR;

EID: 79955106529     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2011/415719     Document Type: Review

References (27)

1. Silverberg S. J., Bone H. G. 3rd, Marriott T. B., Locker F. G., Thys-Jacobs S., Dziem G., Kaatz S., Sanguinetti E. L., Bilezikian J. P., Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism New England Journal of Medicine 1997 337 21 1506 1510 (Pubitemid 27495776)
2. Yamauchi M., Sugimoto T., Yamaguchi T., Yano S., Kanzawa M., Kobayashi A., Chihara K., Association of polymorphic alleles of the calcium-sensing receptor gene with the clinical severity of primary hyperparathyroidism Clinical Endocrinology 2001 55 3 373 379 (Pubitemid 32825492)
3. Kawata T., Imanishi Y., Kobayashi K., Kenko T., Wada M., Ishimura E., Miki T., Nagano N., Inaba M., Arnold A., Nishizawa Y., Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism European Journal of Endocrinology 2005 153 4 587 594 (Pubitemid 41556286)
4. Dillon M. L., Frazee L. A., Cinacalcet for the treatment of primary hyperparathyroidism. American Journal of Therapeutics. In press
5. Padmanabhan H., Cinacalcet in the treatment of intractable hypercalcemia following two neck exploration surgeries for primary hyperparathyroidism Southern Medical Journal 2010 103 3 272 275
6. Sheldon D. G., Lee F. T., Neil N. J., Ryan J. A., Duh Q. Y., Butler J. A., Hart M. J., Clark O. H., Freischlag J. A., Schneider P. D., Way L., Surgical treatment of hyperparathyroidism improves health-related quality of life Archives of Surgery 2002 137 9 1022 1028 (Pubitemid 35006363)
7. Sitges-Serra A., Garcia L., Prieto R., Pena M. J., Nogues X., Sancho J. J., Effect of parathyroidectomy for primary hyperparathyroidism on bone mineral density in postmenopausal women British Journal of Surgery 2010 97 7 1013 1019
8. Auroy Y., Benhamou D., Pequignot F., Bovet M., Jougla E., Lienhart A., Mortality related to anaesthesia in France: analysis of deaths related to airway complications Anaesthesia 2009 64 4 366 370
9. Glenshaw M., Madzimbamuto F. D., Anaesthesia associated mortality in a district hospital in Zimbabwe: 1994 to 2001 Central African Journal of Medicine 2005 51 3-4 39 44
10. Sajid-Crockett S., Singer F. R., Hershman J. M., Cinacalcet for the treatment of primary hyperparathyroidism Metabolism 2008 57 4 517 521 (Pubitemid 351317967)
11. Peacock M., Bilezikian J. P., Klassen P. S., Guo M. D., Turner S. A., Shoback D., Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism Journal of Clinical Endocrinology and Metabolism 2005 90 1 135 141 (Pubitemid 40116646)
12. Shoback D. M., Bilezikian J. P., Turner S. A., McCary L. C., Guo M. D., Peacock M., The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism Journal of Clinical Endocrinology and Metabolism 2003 88 12 5644 5649 (Pubitemid 38033028)
13. Iglesias P., Ais G., Gonzlez A., Tajada P., Arivalo C. G., Pardo E. F., Dez J. J., Acute and one-year effects of cinacalcet in patients with persistent primary hyperparathyroidism after unsuccessful parathyroidectomy American Journal of the Medical Sciences 2008 335 2 111 114 (Pubitemid 351253406)
14. Marcocci C., Chanson P., Shoback D., Bilezikian J., Fernandez-Cruz L., Orgiazzi J., Henzen C., Cheng S., Sterling L. R., Lu J., Peacock M., Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism Journal of Clinical Endocrinology and Metabolism 2009 94 8 2766 2772
15. Akinci B., Comlekci A., Tankurt E., Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis Experimental and Clinical Endocrinology and Diabetes 2009 117 3 142 145
16. Berndt T., Kumar R., Phosphatonins and the regulation of phosphate homeostasis Annual Review of Physiology 2007 69 341 359 (Pubitemid 46457647)
17. Peacock M., Bolognese M. A., Borofsky M., Scumpia S., Sterling L. R., Cheng S., Shoback D., Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study Journal of Clinical Endocrinology and Metabolism 2009 94 12 4860 4867
18. Vezzoli G., Terranegra A., Arcidiacono T., Biasion R., Coviello D., Syren M. L., Paloschi V., Giannini S., Mignogna G., Rubinacci A., Ferraretto A., Cusi D., Bianchi G., Soldati L., R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria Kidney International 2007 71 11 1155 1162 (Pubitemid 46809131)
19. Rothe H. M., Shapiro W. B., Sun W. Y., Chou S. Y., Calcium-sensing receptor gene polymorphism Arg990Gly and its possible effect on response to cinacalcet HCl Pharmacogenetics and Genomics 2005 15 1 29 34 (Pubitemid 43205524)
20. Rothe H., Shapiro W. B., Sun W. Y., Matalon A., Calcium-sensing receptor gene polymorphism Arg 990 Gly influences the response to calcimimetic agents in end-stage kidney disease patients with secondary hyperparathyroidism Personalized Medicine 2008 5 2 109 116 (Pubitemid 351586526)
21. Kalantar-Zadeh K., Miller J. E., Kovesdy C. P., Mehrotra R., Lukowsky L. R., Streja E., Ricks J., Jing J., Nissenson A. R., Greenland S., Norris K. C., Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients Journal of Bone and Mineral Research 2010 25 12 2448 2458
22. de Boer I. H., Gorodetskaya I., Young B., Hsu C. Y., Chertow G. M., The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease Journal of the American Society of Nephrology 2002 13 11 2762 2769 (Pubitemid 35216046)
23. Vezzoli G., Terranegra A., Arcidiacono T., Gambaro G., Milanesi L., Mosca E., Soldati L., Calcium kidney stones are associated with a haplotype of the calcium-sensing receptor gene regulatory region Nephrology Dialysis Transplantation 2010 25 7 2245 2252
24. Serra A. L., Schwarz A. A., Wick F. H., Marti H. P., Wuthrich R. P., Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism Nephrology Dialysis Transplantation 2005 20 7 1315 1319 (Pubitemid 41430604)
25. Cho M. E., Duan Z., Chamberlain C. E., Reynolds J. C., Ring M. S., Mannon R. B., Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism Transplantation Proceedings 2010 42 9 3554 3558
26. Potter L. K., Greller L. D., Cho C. R., Nuttall M. E., Stroup G. B., Suva L. J., Tobin F. L., Response to continuous and pulsatile PTH dosing: a mathematical model for parathyroid hormone receptor kinetics Bone 2005 37 2 159 169 (Pubitemid 40962422)
27. Franceschini N., Joy M. S., Kshirsagar A., Cinacalcet HCl: a calcimimetic agent for the management of primary and secondary hyperparathyroidism Expert Opinion on Investigational Drugs 2003 12 8 1413 1421 (Pubitemid 36949698)